Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor
Tian Niu(Zhejiang University), Kailin Li(Zhejiang University), Jiang Li(Zhejiang University), Zhesheng Zhou(Zhejiang University), Ju-Eun Hong(Zhejiang University), Xuankun Chen(Zhejiang University), Xiaowu Dong(Zhejiang Lab), Qiaojun He(Zhejiang Lab), Ji Cao(Zhejiang Lab), Bo Yang(Zhejiang University), Cheng‐Liang Zhu(Zhejiang Lab)
Cited by 77Open Access